Strata Critical Medical (SRTA) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 28, 2026, will be held virtually, allowing shareholders to vote and ask questions online.

• The company completed a major strategic shift in 2025, selling its passenger business to Joby Aviation and rebranding as a pure-play medical logistics and services provider.

• Two Class II directors are up for election for terms expiring in 2029; board recommends voting for all nominees.

• Deloitte & Touche LLP is recommended for ratification as independent auditor for 2026.

• Advisory vote on executive compensation (Say-on-Pay) is included, with board recommending approval.

Voting matters and shareholder proposals

• Proposals include election of two Class II directors, ratification of Deloitte as auditor, and Say-on-Pay vote.

• Shareholders of record as of March 31, 2026, are eligible to vote.

• Board recommends voting for all proposals.

• Procedures for submitting shareholder proposals and board nominees for the 2027 meeting are detailed, with deadlines and requirements specified.

Board of directors and corporate governance

• Board will reduce to seven members after the meeting, with staggered three-year terms for directors.

• Board skills matrix highlights expertise in executive leadership, governance, finance, healthcare, and risk management.

• Lead Independent Director role will transition to Andrew Lauck after the meeting.

• Board committees (Audit, Compensation, Nominating/Governance) are composed of independent directors and meet regularly.

• Corporate governance guidelines, code of ethics, and stockholder communication processes are in place.